Search images on Google      Product Monograph

Active Ingredients:

• tremelimumab, 20 MG/ML

DIN: 02541009

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Schedule: Prescription

Company: ASTRAZENECA CANADA INC  –  official site

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO)
• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO)
• L01 - ANTINEOPLASTIC AGENTS (WHO)

Pharmaceutical standard: MFR

 

External Links for Imjudo:

Search on Google

• Imjudo side effects
• Imjudo dosage
• tremelimumab side effects
• tremelimumab dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find imjudo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.